MapLight Therapeutics, Inc. (MPLT)
7.25
+0.18
(+2.55%)
USD |
NASDAQ |
Nov 13, 16:00
7.25
0.00 (0.00%)
After-Hours: 19:59
MapLight Therapeutics Debt to Equity Ratio : 0.0057 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0057 |
| March 31, 2026 | 0.014 |
| December 31, 2025 | 0.0127 |
| September 30, 2025 | 0.0257 |
| Date | Value |
|---|---|
| June 30, 2025 | 0.0973 |
| March 31, 2025 | 0.0688 |
| June 30, 2024 | |
| March 31, 2024 | 0.0336 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Oncolytics Biotech, Inc. | -0.0546 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6888 |
| Anixa Biosciences, Inc. | 0.012 |
| Vicapsys Life Sciences, Inc. | -0.1759 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 368.35M |
| Total Liabilities (Quarterly) | 20.05M |
| Shareholders Equity (Quarterly) | 348.30M |
| Current Ratio | 16.52 |
| Net Debt Paydown Yield | 0.05% |